Results From a Phase 2, Open‐Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of <scp>GLM101</scp> in Three Adult Patients With <scp>PMM2</scp> ‐ <scp>CDG</scp>

Mercedes Serrano, Florencia Epifani, Rose Marino, Peter McWilliams

Open source

DOI: 10.1002/jimd.70240
Published: 2026-09
Container: Journal of Inherited Metabolic Disease
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jimd.70240,
  title = {Results From a Phase 2, Open‐Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of
                    <scp>GLM101</scp>
                    in Three Adult Patients With
                    <scp>PMM2</scp>
                    ‐
                    <scp>CDG</scp>},
  author = {Mercedes Serrano and Florencia Epifani and Rose Marino and Peter McWilliams},
  year = {2026},
  journal = {Journal of Inherited Metabolic Disease},
  doi = {10.1002/jimd.70240},
  url = {https://doi.org/10.1002/jimd.70240}
}

RIS

TY  - JOUR
TI  - Results From a Phase 2, Open‐Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of
                    <scp>GLM101</scp>
                    in Three Adult Patients With
                    <scp>PMM2</scp>
                    ‐
                    <scp>CDG</scp>
AU  - Mercedes Serrano
AU  - Florencia Epifani
AU  - Rose Marino
AU  - Peter McWilliams
PY  - 2026
JO  - Journal of Inherited Metabolic Disease
DO  - 10.1002/jimd.70240
UR  - https://doi.org/10.1002/jimd.70240
ER  -

APA

Serrano, M., Epifani, F., Marino, R., & McWilliams, P. (2026). Results From a Phase 2, Open‐Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of <scp>GLM101</scp> in Three Adult Patients With <scp>PMM2</scp> ‐ <scp>CDG</scp>. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70240

Source records

crossref · retrieved 2026-09-25T03:39:18.366Z